Herpes Simplex Virus 1

You can carry HSV-1 (herpes simplex virus type 1) in your genital tract and pass it to a partner without ever seeing a sore. This test looks for the virus directly in vaginal secretions and is the most sensitive way to confirm active viral presence at the moment of collection. Because HSV sheds intermittently, this test is most useful when you have symptoms, visible lesions, or a clinical reason to suspect active infection. The CDC advises against random or blind genital swabs in the absence of lesions as a way to diagnose genital HSV, because a single asymptomatic swab has low sensitivity and a negative result does not rule out infection.

Most adults associate HSV-1 with cold sores around the mouth, but genital HSV-1 has become increasingly common, and at least half of new genital herpes cases in the U.S. are now attributable to HSV-1 rather than HSV-2. A vaginal swab can confirm what is actually happening in your body at the time of collection, not just what your immune system remembers from a past exposure.

What This Test Actually Measures

This is a molecular test that looks for HSV-1 DNA (the virus's genetic material) in a vaginal swab. Unlike a blood test, which detects antibodies your body has made against the virus, a swab detects the virus itself when it is shedding from the skin or mucous membranes of the genital tract.

Because the test detects active virus, a positive result tells you the virus is present at that site, on that day. A negative result means no virus was detected in that sample, but it does not rule out infection, since HSV sheds intermittently and may not be present on every day you test. This is why CDC guidance reserves swab-based diagnosis for moments when lesions or symptoms are present, rather than as a general screen.

Why Genital HSV-1 Is Common but Often Missed

In a large U.S. lab series of more than 60,000 cervicovaginal samples, 14% of women's specimens tested positive for HSV, and about 32% of those positive samples (roughly 2,600 women) were HSV-1. That points to widespread genital HSV-1 that is rarely caught by routine care, since most of these women were not being evaluated specifically for herpes.

In sexually active women being tested only for chlamydia or gonorrhea, vaginal swabs also picked up unsuspected HSV-1 and HSV-2. In one study of HIV-negative South African women, genital HSV-1 DNA was found in 9.6% (24 of 251), and more than half of those reached a significant shedding level, yet none had visible lesions. The takeaway: standard STI panels often skip HSV entirely, so the infection can go undetected for years.

Asymptomatic Shedding and Transmission Risk

After a first episode of genital HSV-1, daily self-collected anogenital swabs show virus on about 12.1% of days at 2 months, dropping to about 7.1% of days by 11 months. Visible lesions appear on only about 2.6% to 3.8% of days, which means the majority of shedding happens with no symptoms at all.

This is why people can transmit HSV without realizing they are infectious. The virus can be present on the skin and mucous membranes during periods when nothing feels wrong, and a partner can pick it up during ordinary sexual contact. A confirmed positive result during a symptomatic episode can inform decisions about how to talk to partners, when to use barrier protection, and whether to consider suppressive antiviral therapy.

Pregnancy and Neonatal Risk

Neonatal herpes, while rare (roughly 10 to 16 cases per 100,000 live births in the U.S.), can have serious consequences and most often results from maternal genital HSV present in the birth canal during delivery. Global modeling estimates roughly 14,000 cases of neonatal herpes worldwide each year, with most cases linked to maternal HSV infection.

If you are planning a pregnancy or are currently pregnant, knowing whether you carry genital HSV-1 changes how your delivery is managed. ACOG and CDC recommend cesarean delivery when active genital lesions or prodromal symptoms are present at the onset of labor, which is the primary intervention for preventing neonatal transmission. Your obstetric team may also offer suppressive antiviral medication in the last weeks of pregnancy, and a vaginal swab can help confirm active virus when lesions are present at the time of labor.

HIV and Other Co-Infections

Most of the data linking genital HSV to higher HIV acquisition risk come from HSV-2 studies, where HSV-2 infection is associated with a roughly two- to three-fold higher risk of HIV acquisition. The specific contribution of genital HSV-1 to HIV risk is less well characterized. A study of HIV-infected women in Kenya detected HSV DNA in 17% of cervical swabs, and HSV shedding was tied to factors like hormonal contraception and pregnancy.

If you are at higher risk of HIV exposure or already managing HIV, knowing your HSV status can inform conversations about overall transmission risk and decisions about prevention tools like pre-exposure prophylaxis (PrEP).

How This Test Compares to Other Options

Vaginal swab PCR is far more sensitive than viral culture, which used to be the standard. In studies of mucocutaneous samples, PCR detects many additional low-level positives that culture misses entirely. In one comparison, culture caught only about 22 out of 100 HSV-1 infections that PCR identified. A negative culture, especially for HSV-1, is not reliable reassurance.

Blood-based HSV-1 antibody testing answers a different question. It tells you whether you have been exposed at some point in your life, but it cannot distinguish oral from genital infection. A vaginal swab is the test that pinpoints active genital infection at the time of sampling. The USPSTF currently recommends against routine serologic screening for genital herpes in asymptomatic adults.

When Results Can Be Misleading

Because HSV sheds intermittently, a single negative swab does not rule out genital HSV-1. After a first episode, virus may be detectable on as few as 5% to 7% of days within a year. The shorter the sampling window, the more likely you are to miss a shedding day. This is the main reason CDC guidance advises against using blind swabs to diagnose genital HSV in the absence of lesions.

• Recent intercourse or douching: can transiently disturb the local sampling area and reduce the cellular material collected, lowering the chance of detecting virus that is present at low levels.
• Sampling technique: an improperly inserted or rotated swab may not capture enough material from the vaginal walls, which is why proper insertion and rotation matter for a reliable result.
• Active antiviral medication: if you are currently taking acyclovir, valacyclovir, or famciclovir, viral shedding is suppressed and a negative result may simply reflect the drug's effect rather than absence of infection.
• Timing relative to outbreaks: shedding is more frequent in the first months after a new infection and during prodromal symptoms, and less frequent during long quiet stretches, so the same person can swab negative one week and positive the next.

Why One Reading Is Not Enough

A single swab is a snapshot of one moment in a highly variable biological process. Researchers who study HSV shedding rely on daily swabs for weeks or months at a time, precisely because shedding is episodic and short-lived. Many subclinical reactivations last only hours, which is why a one-time test can easily miss them.

If you have visible lesions, prodromal symptoms, or another clinical reason to suspect genital HSV-1, a swab during that episode is the highest-yield use of this test. Repeat testing during recurrent symptomatic episodes is more informative than swabbing on quiet days. Major guidelines do not recommend routine periodic PCR swab screening of asymptomatic individuals, so the value of this test is highest when symptoms or specific clinical questions prompt it.

What to Do With an Unexpected Result

If your swab is positive for HSV-1, the next step is to confirm whether this represents a first episode or a recurrence of a long-standing infection. Pairing the swab with a blood-based HSV-1 IgG antibody test can help: a positive swab with negative antibodies suggests a recent, brand-new infection, while positive antibodies suggest the infection has been present for some time.

A positive result is also a reason to discuss suppressive antiviral therapy with a clinician, especially if you have frequent outbreaks, a partner without HSV-1, or are planning a pregnancy. If your swab is negative but you have ongoing genital symptoms, consider repeating during a symptomatic episode or asking for a lesion panel that also tests for HSV-2, syphilis, and varicella zoster virus, since these can look similar clinically.